Targeting tumor-associated macrophages to reverse antitumor drug resistance
Aging · 2024
DOI: 10.18632/aging.205858 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Aging, 2024. Verfasst von Sheng Li und 3 weiteren Autor:innen. Beteiligte Einrichtung: The Second Hospital of Jilin University, Changchun, China. Hauptthemen laut MEDLINE: Drug Resistance, Neoplasm, Tumor-Associated Macrophages, Tumor Microenvironment, Antineoplastic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 189 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Currently, antitumor drugs show limited clinical outcomes, mainly due to adaptive resistance. Clinical evidence has highlighted the importance of the tumor microenvironment (TME) and tumor-associated macrophages (TAMs) in tumor response to conventional antitumor drugs. Preclinical studies show that TAMs following antitumor agent can be reprogrammed to an immunosuppressive phenotype and proangiogenic activities through different mechanisms, mediating drug resistance and poor prognosis. Potential extrinsic inhibitors targeting TAMs repolarize to an M1-like phenotype or downregulate proangiogenic function, enhancing therapeutic efficacy of anti-tumor therapy. Moreover, pharmacological modulation of macrophages that restore the immune stimulatory characteristics is useful to reshaping the tumor microenvironment, thus further limiting tumor growth. This review aims to introduce macrophage response in tumor therapy and provide a potential therapeutic combination strategy of TAM-targeting immunomodulation with conventional antitumor drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Second Hospital of Jilin University, Changchun, China.
- Department of Hepatobiliary and Pancreatic Surgery, Second Hospital of Jilin University, Changchun, China.
- Department of Radiotherapy, The Second Hospital of Jilin University, Changchun, China.
Zitieren
APA
Li, S., Sheng, J., Zhang, D., & Qin, H. (2024). Targeting tumor-associated macrophages to reverse antitumor drug resistance. Aging. https://doi.org/10.18632/aging.205858
Vancouver
Li S, Sheng J, Zhang D, Qin H. Targeting tumor-associated macrophages to reverse antitumor drug resistance. Aging. 2024. doi:10.18632/aging.205858
BibTeX
@article{Li2024,
author = {Li, Sheng and Sheng, Jiyao and Zhang, Dan and Qin, Hanjiao},
title = {Targeting tumor-associated macrophages to reverse antitumor drug resistance},
journal = {Aging},
year = {2024},
doi = {10.18632/aging.205858}
}
EUVIMED